You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三星醫療(601567.SH):醫療集團擬實施增資擴股 合計引資2.664億元
格隆匯 10-27 00:56

格隆匯10月27日丨三星醫療(601567.SH)公佈,公司全資子公司寧波奧克斯醫療集團有限公司(以下簡稱“醫療集團”)進行增資擴股,參與增資的對象為公司實際控制人鄭堅江、公司董事沈國英、樑嵩巒、繆錫雷,自然人郭粟、吳爽、蔡曉鑫、鄧俊、顧微微及寧波奧合企業管理合夥企業(有限合夥)、寧波醫合企業管理合夥企業(有限合夥),合計增資2.664億元人民幣。

其中鄭堅江增資1.84億元人民幣,沈國英增資699.3萬元人民幣,樑嵩巒增資177.6萬元人民幣,繆錫雷增資133.2萬元人民幣,郭粟增資111萬元人民幣,吳爽增資111萬元人民幣,蔡曉鑫增資111萬元人民幣,鄧俊增資66.6萬元人民幣,顧微微增資33.3萬元人民幣,寧波奧合企業管理合夥企業(有限合夥)增資6027.3萬元人民幣,寧波醫合企業管理合夥企業(有限合夥)增資777萬元人民幣,合計增資2.664億元人民幣(其中1.2億元作為實收資本,1.464億元計入資本公積金)。

本次增資公司放棄優先認購權。本次增資完成後,醫療集團註冊資本為9.2億元。增資後,醫療集團仍為公司控股子公司。本次增資事項將進一步增加醫療集團的資本實力,有利於推動公司醫療產業的快速發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account